Related Experiment Video
Updated: Aug 9, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Prevalence of infective endocarditis in patients with systemic lupus erythematosus
C S Miller1, R M Egan, D A Falace
1Department of Oral Health Science, University of Kentucky College of Dentistry, Lexington 40536-0084, USA.
Insights
Systemic lupus erythematosus (SLE) patients show a higher prevalence of cardiac valve issues. While no direct link to infective endocarditis was found, some SLE patients may need antibiotic prophylaxis for dental procedures.
Area of Science:
- Cardiology
- Rheumatology
- Infectious Diseases
Background:
- Patients with systemic lupus erythematosus (SLE) exhibit a greater prevalence of cardiac valve dysfunction due to Libman-Sacks lesions.
- These cardiac abnormalities may increase the risk of infective endocarditis (IE) in SLE patients.
Purpose of the Study:
- To investigate the association between SLE, valvular abnormalities, and infective endocarditis.
- To determine the prevalence of cardiac valve issues in patients diagnosed with SLE.
Main Methods:
- A retrospective chart review was conducted on 361 patients with a diagnostic code for SLE.
- Records were analyzed to identify valvular abnormalities and a history of infective endocarditis.
Main Results:
- Of 275 patients meeting SLE criteria, 18.5% had clinically detectable heart murmurs requiring further investigation.
- Clinically significant or potentially significant valvular abnormalities were found in 4.4% of the SLE cohort.
- No cases directly linked infective endocarditis to a diagnosed SLE condition.
Conclusions:
- A significant percentage of SLE patients present with cardiac murmurs, necessitating further evaluation.
- A notable proportion of SLE patients have valvular abnormalities, potentially requiring antibiotic prophylaxis before dental procedures.
- The study did not establish a direct association between infective endocarditis and diagnosed SLE, but clinical vigilance is advised.
Background:
Compared with the general population, patients with systemic lupus erythematosus, or SLE, have an increased prevalence of functionally impaired cardiac valves due to the presence of Libman-Sacks lesions. These lesions may place patients with SLE at risk of developing infective endocarditis, or IE.
Methods:
The authors performed a retrospective chart review to determine the association between SLE with valvulopathy and IE. They reviewed the records of 361 patients from two health care facilities who had the diagnostic code of SLE.
Results:
Of the 275 records that met the 1982 revised American Rheumatism Association criteria for SLE, 51 (18.5 percent) were for patients who had a clinically detectable heart murmur that resulted in echocardiography being performed. Nine (3.3 percent) of the 275 patients had a clinically significant valvular abnormality, three (1.1 percent) had a potentially significant valvular abnormality, and one (0.4 percent) had a history of IE that was diagnosed two years before her diagnosis of SLE was made.
Conclusions:
The findings suggest that 18.5 percent of this cohort of patients with SLE had a clinically detectable heart murmur that would require further investigation to determine its significance. Furthermore, between 3.3 and 4.4 percent of the study population had cardiac valve abnormalities that potentially required antibiotic prophylaxis before certain dental procedures. However, the authors identified no cases that demonstrated an association between IE and diagnosed SLE.
Clinical Implications:
Dentists should query their patients with SLE about their cardiac status and consult with the patient's physician if the cardiac status is unknown. Patients with confirmed valvular abnormalities should receive antibiotic prophylaxis for designated bacteremia-producing dental procedures.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

